Celebrating 25 years Est 1999-2024
*Across 3 years $2158.56 only $755.50
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated...
Zealand Pharma Announces Financial Results for the First Nine Months of 2024 Company announcement – No. 49 / 2024 Zealand Pharma Announces...
Zealand Pharma provides U.S. regulatory update on dasiglucagon in congenital hyperinsulinism Company announcement – No. 48 / 2024 Zealand Pharma...
Zealand Pharma announces that Boehringer receives U.S. FDA Breakthrough Therapy designation and initiates two Phase III trials in MASH for...
Total number of shares and voting rights in Zealand Pharma A/S on September 30, 2024 Company announcement – No. 46 / 2024 Total number of shares...
Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants Company announcement – No. 45 / 2024 Zealand Pharma...
Zealand Pharma announces positive topline results from 13-week Phase 1b multiple ascending dose clinical trial with GLP-1/GLP-2 receptor dual...
Total number of shares and voting rights in Zealand Pharma on August 30, 2024 Company announcement – No. 42 / 2024 Total number of shares and...
Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants Company announcement – No. 41 / 2024 Zealand Pharma...
Zealand Pharma major shareholder announcement: Bank of America Corporation Company announcement – No. 40 / 2024 Zealand Pharma major shareholder...
Zealand Pharma Announces Financial Results for the First Half of 2024 Company announcement - No. 39 / 2024 Zealand Pharma Announces Financial...
Zealand Pharma major shareholder announcement: Van Herk Investments Company announcement – No. 38 / 2024 Zealand Pharma major shareholder...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.